Co-Authors
This is a "connection" page, showing publications co-authored by Tingbo Liang and Yunqing Qiu.
Connection Strength
1.063
-
Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial. Eur J Pharm Sci. 2021 Feb 01; 157:105631.
Score: 0.227
-
Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study. Front Med (Lausanne). 2020; 7:347.
Score: 0.222
-
Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020 04 21; 369:m1443.
Score: 0.220
-
Cross-neutralization of RBD mutant strains of SARS-CoV-2 by convalescent patient derived antibodies. Biotechnol J. 2021 Nov; 16(11):e2100207.
Score: 0.060
-
Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage site. Emerg Microbes Infect. 2020 Dec; 9(1):1474-1488.
Score: 0.057
-
Decreased B Cells on Admission Associated With Prolonged Viral RNA Shedding From the Respiratory Tract in Coronavirus Disease 2019: A Case-Control Study. J Infect Dis. 2020 07 06; 222(3):367-371.
Score: 0.056
-
Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study. Am J Gastroenterol. 2020 07; 115(7):1075-1083.
Score: 0.056
-
A Deep Learning System to Screen Novel Coronavirus Disease 2019 Pneumonia. Engineering (Beijing). 2020 Oct; 6(10):1122-1129.
Score: 0.056
-
[Management of COVID-19: the Zhejiang experience]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25; 49(2):147-157.
Score: 0.055
-
[Management of corona virus disease-19 (COVID-19): the Zhejiang experience]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 21; 49(1):147-157.
Score: 0.054